“We hope to reduce disparities and build cancer treatment capacities by encouraging collaborations across borders"
New York, NY (PRWEB) March 06, 2012
The Global Prostate Cancer Alliance launches this week, connecting international men’s health advocates, health care professionals and researchers from around the world in a united effort to develop prostate cancer patient advocacy strategies.
The Global Prostate Cancer Alliance is an inclusive coalition of national and regional prostate cancer stakeholders from around the world. Founding members include organizations from Afghanistan, Australia, Austria, Canada, England, Germany, Hungary, Israel, Italy, Portugal, Slovakia, Tanzania and the United States. More organizations from Europe and others from Asia, Oceania and Latin America are expected to join before year’s end.
This effort takes on added urgency as new treatments for prostate cancer are approved in one country, but denied in another. For example, Abiraterone, a drug used in a drug used in castration-resistant prostate cancer approved in the United States by the US Food and Drug Administration but not available for advanced prostate cancer patients in England as determined by the National Health Service. Global Prostate Cancer Alliance collaborations will promote opportunities for fundamental research and help build patient advocacy for improving national health care policy decisions for all national health care stakeholders.
“There is a damaging divide between the developed and developing world regarding cancer treatment. We hope to reduce disparities and build cancer treatment capacities by encouraging collaborations across borders and continents," according to Global Prostate Cancer Alliance Organizing Secretary Darryl Mitteldorf, LCSW.
“Knowing that prostate cancer organizations are working together gives me the good feeling of hope,” said prostate cancer survivor Roberto Gonzalez.
The Global Prostate Cancer Alliance will initiate research regarding disparities in prostate cancer prevalence and access to treatment, help develop patient advocacy organizations in countries and regions where none exist, facilitate roundtable discussion events, produce online content regarding national and international prostate cancer advocacy and treatment and will encourage cross border and cross discipline collaborations.
“Advocacy drives awareness and implementation. The Global Prostate Cancer Alliance will help reduce the global prostate cancer burden by leveraging developed systems and understanding lesser developed systems,” said Mr. Mitteldorf.
About the Global Prostate Cancer Alliance
Founded in 2012, the Global Prostate Cancer Alliance is an international coalition focused on understanding the diverse issues faced by prostate cancer researchers, advocates and clinicians in various regions throughout the world. For more information, visit http://www.prostatecanceralliance.org